drugset / Trial / NCT03122678

Thiamine Supplementation in Patients With Septic Shock

NCT03122678

Phase 1 Withdrawn The Cleveland Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine if intravenous thiamine would decrease the time to reversal of shock in patients with septic shock.

Timeline

Start
2016-11-05
Primary completion
2019-03-14
Completion
2019-03-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiamine Other / unclassified 200 mg Intravenous